Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Fixed-Dose, 8-Week Treatment, Multi-Center Trial Evaluating the Efficacy and the Safety of 3 Oral Doses of Surinabant as an Aid to Smoking Cessation in Cigarette Smokers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2014
Price :
$35
*
At a glance
- Drugs Surinabant (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- Acronyms SURSMOKE
- Sponsors Sanofi
- 09 Sep 2014 New trial record